Medical Properties Stock Forecast
NYSE: MPTReal EstateReal Estate Investment TrustsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
MPT analyst consensus
Consensus (8 analysts)
none
Avg. price target
$5.13+60.82%
- Strong buy 3
- Buy 0
- Hold 3
- Sell 0
- Strong sell 2
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 8 Wall Street analysts covering Medical Properties (2026-10-07), 3 rate the stock a buy or strong buy, 3 rate it a hold and 2 rate it a sell or strong sell, for a consensus rating of "none". The average 12-month price target is $5.13, with a high estimate of $7.00 and a low estimate of $4.25. The average target implies upside of 60.8% from the current price of $3.19.
The spread between the highest and lowest targets is 64.7%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for MPT.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 3 | 38% |
| Buy | 0 | 0% |
| Hold | 3 | 38% |
| Sell | 0 | 0% |
| Strong sell | 2 | 25% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $4.25 | +33.23% |
| Average target | $5.13 | +60.82% |
| High target | $7.00 | +119.44% |